Requena D, Supo-Escalante R, Sheen P, Zimic M
PLoS One. 2024; 19(8):e0309352.
PMID: 39208342
PMC: 11361689.
DOI: 10.1371/journal.pone.0309352.
Suresh P, Thulasidharan S, Kumar A, Sunil S, Roy M, Ramesh V
Am J Trop Med Hyg. 2024; 111(1):161-167.
PMID: 38772358
PMC: 11229631.
DOI: 10.4269/ajtmh.24-0042.
Niranjan V, Uttarkar A, Murali K, Niranjan S, Gopal J, Kumar J
Molecules. 2022; 27(19).
PMID: 36234683
PMC: 9571707.
DOI: 10.3390/molecules27196150.
Rajendran A, Palaniyandi K
Curr Microbiol. 2022; 79(11):348.
PMID: 36209317
DOI: 10.1007/s00284-022-03032-y.
Shrestha D, Maharjan B, Thapa J, Akapelwa M, Bwalya P, Chizimu J
Curr Issues Mol Biol. 2022; 44(9):4132-4141.
PMID: 36135195
PMC: 9497661.
DOI: 10.3390/cimb44090283.
Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis.
Shi D, Zhou Q, Xu S, Zhu Y, Li H, Xu Y
Infect Drug Resist. 2022; 15:4985-4994.
PMID: 36065280
PMC: 9440668.
DOI: 10.2147/IDR.S368444.
Intragenic Distribution of IS in Clinical Mycobacterium tuberculosis Strains: Bioinformatic Evidence for Gene Disruption Leading to Underdiagnosed Antibiotic Resistance.
Antoine R, Gaudin C, Hartkoorn R
Microbiol Spectr. 2021; 9(1):e0001921.
PMID: 34287057
PMC: 8552512.
DOI: 10.1128/Spectrum.00019-21.
Determining the unbinding events and conserved motions associated with the pyrazinamide release due to resistance mutations of pyrazinamidase.
Sheik Amamuddy O, Musyoka T, Boateng R, Zabo S, Tastan Bishop O
Comput Struct Biotechnol J. 2020; 18:1103-1120.
PMID: 32489525
PMC: 7251373.
DOI: 10.1016/j.csbj.2020.05.009.
Metallochaperones Are Needed for Mycobacterium tuberculosis and Escherichia coli Nicotinamidase-Pyrazinamidase Activity.
Sheen P, Monsalve A, Campos J, Huerta R, Antiparra R, Arteaga H
J Bacteriol. 2019; 202(2).
PMID: 31636108
PMC: 6941528.
DOI: 10.1128/JB.00331-19.
A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.
Yadon A, Maharaj K, Adamson J, Lai Y, Sacchettini J, Ioerger T
Nat Commun. 2017; 8(1):588.
PMID: 28928454
PMC: 5605632.
DOI: 10.1038/s41467-017-00721-2.
Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
Sengstake S, Bergval I, Schuitema A, de Beer J, Phelan J, de Zwaan R
BMC Infect Dis. 2017; 17(1):491.
PMID: 28697808
PMC: 5506614.
DOI: 10.1186/s12879-017-2594-3.
A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis.
Whitfield M, Soeters H, Warren R, York T, Sampson S, Streicher E
PLoS One. 2015; 10(7):e0133869.
PMID: 26218737
PMC: 4517823.
DOI: 10.1371/journal.pone.0133869.
Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.
Ramirez-Busby S, Valafar F
Antimicrob Agents Chemother. 2015; 59(9):5267-77.
PMID: 26077261
PMC: 4538510.
DOI: 10.1128/AAC.00204-15.
Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility.
Vats C, Dhanjal J, Goyal S, Gupta A, Bharadvaja N, Grover A
BMC Genomics. 2015; 16 Suppl 2:S14.
PMID: 25708048
PMC: 4331714.
DOI: 10.1186/1471-2164-16-S2-S14.
Mechanisms of Pyrazinamide Action and Resistance.
Zhang Y, Shi W, Zhang W, Mitchison D
Microbiol Spectr. 2014; 2(4):1-12.
PMID: 25530919
PMC: 4268777.
DOI: 10.1128/microbiolspec.MGM2-0023-2013.
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.
Yoon J, Nam J, Kim K, Ro Y
World J Microbiol Biotechnol. 2014; 30(11):2821-8.
PMID: 25034468
DOI: 10.1007/s11274-014-1706-0.
Characterization of multi-drug resistant Mycobacterium tuberculosis from immigrants residing in the USA using Ion Torrent full-gene sequencing.
Daum L, Fischer G, Sromek J, Khubbar M, Hunter P, Gradus M
Epidemiol Infect. 2013; 142(6):1328-33.
PMID: 24073633
PMC: 4045166.
DOI: 10.1017/S0950268813002409.
Base-calling algorithm with vocabulary (BCV) method for analyzing population sequencing chromatograms.
Fantin Y, Neverov A, Favorov A, Alvarez-Figueroa M, Braslavskaya S, Gordukova M
PLoS One. 2013; 8(1):e54835.
PMID: 23382983
PMC: 3557274.
DOI: 10.1371/journal.pone.0054835.
Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis.
Stoffels K, Mathys V, Fauville-Dufaux M, Wintjens R, Bifani P
Antimicrob Agents Chemother. 2012; 56(10):5186-93.
PMID: 22825123
PMC: 3457413.
DOI: 10.1128/AAC.05385-11.
Role of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase.
Sheen P, Ferrer P, Gilman R, Christiansen G, Moreno-Roman P, Gutierrez A
Am J Trop Med Hyg. 2012; 87(1):153-61.
PMID: 22764307
PMC: 3391041.
DOI: 10.4269/ajtmh.2012.10-0565.